Trexquant Investment’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,436
Closed -$69K 1306
2019
Q1
$69K Buy
+10,436
New +$68.8K ﹤0.01% 944
2018
Q3
Sell
-1,532
Closed -$87K 1323
2018
Q2
$87K Buy
+1,532
New +$77.7K 0.01% 841
2017
Q2
Sell
-5,195
Closed -$376K 1356
2017
Q1
$376K Buy
+5,195
New +$344K 0.05% 655
2016
Q2
Sell
-8,284
Closed -$693K 1232
2016
Q1
$693K Buy
8,284
+5,977
+259% +$493K 0.08% 415
2015
Q4
$228K Sell
2,307
-5,873
-72% -$630K 0.02% 914
2015
Q3
$1M Buy
+8,180
New +$1.11M 0.09% 418
2015
Q2
Sell
-4,685
Closed -$799K 1364
2015
Q1
$799K Sell
4,685
-1,455
-24% -$220K 0.08% 479
2014
Q4
$938K Buy
+6,140
New +$766K 0.17% 187

Other funds holding ELGX

Trexquant Investment's ELGX Position: Q2 2019 in Review

Trexquant Investment sold out of Endologix Inc (ELGX) in Q2 2019, closing a stake of 10,436 shares — an estimated $69K sold.

Trexquant Investment first reported a position in ELGX in Q4 2014 and held it in 8 quarters. The position peaked at $1M in Q3 2015. 75 funds tracked by Wall St. Rank hold ELGX as of Q2 2019.

  • Trexquant Investment reported no remaining Endologix Inc position as of Q2 2019 after selling out during the quarter.
  • Trexquant Investment sold 10,436 Endologix Inc shares in Q2 2019, an estimated $69K.
  • Trexquant Investment first reported a position in Endologix Inc in Q4 2014 and held it in 8 quarters.
  • Trexquant Investment's Endologix Inc position peaked at $1M in Q3 2015.
  • 75 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2019.

Based on Trexquant Investment's 13F filing for Q2 2019, filed 9 Aug 2019.